Evidence map›Paper›PMID 39620650›Full record

ArticleTumori2025

Fertility and abortion: A population-based comparison between women with cancer and those in childbearing age.

Alice Maraschini, Edoardo Corsi Decenti, Serena Donati, Silvia Francisci, Tania Lopez, Rosalba Amodio, Fortunato Bianconi, Emanuela Bovo, Rossella Bruni, Marine Castaing and 19 more

Abstract readComparative Study
In one paragraph

Article in Tumori, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Alice MaraschiniTechnical-Scientific Statistical Service, Italian National Institute of Health, Rome, Italy.ORCID 0000-0003-4754-5385
Edoardo Corsi DecentiNational Centre for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.
Serena DonatiNational Centre for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.ORCID 0000-0002-4607-2072
Silvia FrancisciNational Centre for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.ORCID 0000-0002-1552-1744
Tania LopezNational Centre for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.ORCID 0000-0002-6168-400X
Rosalba AmodioClinical Epidemiology and Cancer Registry Unit, Azienda Ospedaliera Universitaria Policlinico P Giaccone (AOUP), Palermo, Italy.
Fortunato BianconiArea Operativa ICT-PuntoZero Scarl, Perugia, Italy.
Emanuela BovoRegistro Tumori del Veneto, Servizio Epidemiologico Regionale, Azienda Zero, Padova, Italy.
Rossella BruniAgenzia Regionale Strategica per la Salute e il Sociale, AReSS Puglia, Bari, Italy.
Marine CastaingSiracusa Cancer Registry, Health Unit of Siracusa, Siracusa, Italy.
Claudia CirilliDipartimento di Epidemiologia e Comunicazione del Rischio, AUSL di Modena, Modena, Italy.
Rosa Pasqualina De VincenzoFondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.
Giuseppe FurgiueleDirezione Dipartimento di Prevenzione ASP Catanzaro, Catanzaro, Italy.
Linda GuardaSC Osservatorio Epidemiologico ATS Valpadana, Mantova, Italy.
Silvia IacovacciUOC Prevenzione Attiva, ASL Latina, Italy.
Lucia MangoneEuropean Epidemiology Unit, Gynecologic Oncology Department, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.ORCID 0000-0003-4850-2678
Walter MazzuccoClinical Epidemiology and Cancer Registry Unit, Azienda Ospedaliera Universitaria Policlinico P Giaccone (AOUP), Palermo, Italy.
Anna MelcarneRegistro Tumori ASL di Lecce, Lecce, Italy.
Elisabetta MerloUOC Epidemiologia, Agenzia per la Tutela della Salute (ATS) della Brianza, Monza, Italy.
Michael MianInnovation, Research and Teaching Service, Hospital of Bolzano (SABES-ASDAA), Teaching Hospital of the Paracelsus Medizinischen Privatuniversität (PMU), Bozen, Italy.
Giuseppe SampietroHealth Protection Agency of Bergamo (ATS Bergamo), Bergamo, Italy.
Giovanni ScambiaFondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.
Tiziana ScuderiUOSD Registro Tumori, Dipartimento di Prevenzione, ASP Trapani, Italia.
Ausilia SferrazzaASP Ragusa-Dipartimento Medico di Prevenzione, UOSD Registro Tumori, Ragusa, Italy.
Fabrizio StracciAssociazione Nazionale dei Registri Tumori-AIRTUM-Public Health Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Antonina TorrisiRegistro Tumori Integrato, Azienda Ospedaliero Universitaria Policlinico G. Rodolico-San Marco, Catania, Italy.
Vito TrojanoItalian Society of Gynaecology and Obstetrics, Italy.
Maria Francesca VitaleNapoli 3 Sud Cancer Registry, Brusciano, Italy.
Daniela PierannunzioNational Centre for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesConcurrence of pregnancy and cancer diagnosis is increasingly frequent in Italy. The study aimed to compare women with pregnancy-associated cancers (PACs) to those of childbearing age, focusing on fertility, induced abortion, and miscarriage.

methodsThe population-based study included women aged 15-49 years, both with and without PAC, who were residents in the area covered by the 19 participating Cancer Registries between 2003 and 2015 and identified by individual deterministic linkage with the Hospital Discharge Database.

resultsOverall, 2,218,139 obstetrics hospitalizations occurred, covering delivery (75%), induced abortion (14%), and miscarriage (11%). Among 2409 women with PAC, 69% gave birth, 16% had an induced abortion and 15% a miscarriage. Compared with the reference population, the fertility rate in women with PACs was steadily lower (mean values 25.7/1000 vs 37.7/1000), while induced abortion (from 359/1000 - SRR 1.99, 95%CI 1.32-3.00 - in 2003 to 147/1000 - SRR 1.11, 95%CI 0.59-2.09 - in 2015) and miscarriage ratios exhibited a decreasing trend.

conclusionThese results are consistent with international literature and are probably due to advancements in diagnostic and therapeutic opportunities. This is the first Italian population-based study analysing fertility and pregnancy outcomes among women with PAC based on a reliable information on cancer diagnosis.

Indexed as

Abortion, InducedAbortion, SpontaneousFertilityNeoplasmsPregnancy Complications, NeoplasticAdolescentAdultFemaleHumansItalyMiddle AgedPregnancyRegistriesYoung AdultCancercancer registry recordsdeliveryfertilityhospital discharge datainduced abortionmiscarriagepopulation-based datapregnancy outcomerelative risk

Identifiers

PMID39620650
PMCPMC11789424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.